Skip to main content
Log in

A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy

  • Phase I and Pharmacology Trials
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Abstract

Forty-two patients were entered into a phase I trial to evaluate the vitamin A derivative, trans-retinoic acid, in cervical intraepithelial neoplasia. Treatment consisted of four consecutive 24-h applications of retinoids via an inert collagen sponge in a cervical cap. Patients were followed for response at 3-month intervals using cytology, colposcopy, and selected biopsies. Thirty-six patients were evaluable (mild dysplasia, 13; moderate dysplasia, 17; severe dysplasia, 6) with follow-up from 5 to 18 months. Complete regression was seen in 2/14 (14%) patients treated with concentrations of 0.05% → 0.1167% and in 10/22 (45%) patients treated with concentrations of 0.1583% → 0.484% (p < 0.05). One patient with negative biopsies at 12 months has subsequently recurred at 18 months.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lotan R: Effect of vitamin A and its analogues (retinoids) in normal and neoplastic cells. Biochem Biophy Acta 605:33, 1980

    Google Scholar 

  2. Peck GL: Chemoprevention of cancer with retinoids. Gynecol Oncol 12:5331, 1981

    Google Scholar 

  3. Surwit EA, Graham V, Droegemueller W, Alberts D, Chvapil M, Dorr R, Davis J, Meyskens F: Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraephithelial lesions. Am J Obstet Gynecol 143:821, 1982

    Google Scholar 

  4. Meyskens FL, Graham V, Chvapil M, Dorr R, Alberts DS, Surwit EA: A phase I trial of B-all-trans-retinoic acid delivered via a collagen sponge and cervical cap for mild or moderate intraephithelial cervical neoplasia. JNCI 71:921–925, 1983

    Google Scholar 

  5. Chvapil M: Collagen Sponge: Theory and practice of medical applications. J Biomed Mater Res 11:721–726, 1977

    Google Scholar 

  6. Kummet T, Meyskens FL: Vitamin A: A potential inhibitor of human cancer. Semin Oncol X:281–9, 1983

    Google Scholar 

  7. Chu EW, Malmgren RA: An inhibitory effect of vitamin A on the induction of tumors of forestomach and cervix in the Syrian hamster by carcinogenic polycyclic hydrocarbons. Cancer Res 25:884–885, 1965

    Google Scholar 

  8. Lutzner MH, Blanchet-Bardon C: Oral retinoid treatment of human papilloma virus type 5-induced epidermolyplasia verruciformis. New Engl J Med 302:1091, 1980

    Google Scholar 

  9. Reid R: Genital warts and cervical cancer II: Is human papilloma virus infection the trigger to cervical carcinogenesis? Gynecol Oncol 15:239–252, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weiner, S.A., Surwit, E.A., Graham, V.E. et al. A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy. Invest New Drugs 4, 241–244 (1986). https://doi.org/10.1007/BF00179590

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00179590

Key words

Navigation